{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:48:02Z","timestamp":1791301682709,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T00:00:00Z","timestamp":1273276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10552-010-9573-y","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T13:25:14Z","timestamp":1273238714000},"page":"1451-1459","source":"Crossref","is-referenced-by-count":24,"title":["B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case\u2013control study in Greece"],"prefix":"10.1007","volume":"21","author":[{"given":"Maria","family":"Dalamaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley H.","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigoni","family":"Lekka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Triantafilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Karmaniolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Migdalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Dionyssiou-Asteriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,8]]},"reference":[{"key":"9573_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2354.2004.00489.x","volume":"13","author":"A Redaelli","year":"2004","unstructured":"Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL (2004) The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care 13:279\u2013287","journal-title":"Eur J Cancer Care"},{"key":"9573_CR2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0145-2126(03)00023-7","volume":"27","author":"RS Houlston","year":"2003","unstructured":"Houlston RS, Sellick G, Yuille M, Matutes E, Catovsky D (2003) Causation of chronic lymphocytic leukemia\u2013insights from familial disease. Leuk Res 27:871\u2013876","journal-title":"Leuk Res"},{"key":"9573_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11864-002-0012-5","volume":"3","author":"L Andritsos","year":"2002","unstructured":"Andritsos L, Khoury H (2002) Chronic lymphocytic leukemia. Curr Treat Opin Oncol 3:225\u2013231","journal-title":"Curr Treat Opin Oncol"},{"key":"9573_CR4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/aje\/kwf082","volume":"156","author":"JR Cerhan","year":"2004","unstructured":"Cerhan JR, Janney CA, Vachon CM et al (2004) Anthropometric characteristics, physical activity, and risk of non-Hodgkin\u2019s lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 156:527\u2013535","journal-title":"Am J Epidemiol"},{"key":"9573_CR5","doi-asserted-by":"crossref","first-page":"s858","DOI":"10.1093\/ajcn\/86.3.858S","volume":"86","author":"D Barb","year":"2007","unstructured":"Barb D, Williams CJ, Neuwirth AK, Mantzoros CS (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86:s858\u2013s866","journal-title":"Am J Clin Nutr"},{"key":"9573_CR6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/ijc.22762","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Wolk A (2007) Obesity and risk of non-Hodgkin\u2019s lymphoma: a meta-analysis. Int J Cancer 121:1564\u20131570","journal-title":"Int J Cancer"},{"key":"9573_CR7","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/ijc.23176","volume":"122","author":"SC Larsson","year":"2008","unstructured":"Larsson SC, Wolk A (2008) Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer 122:1418\u20131421","journal-title":"Int J Cancer"},{"key":"9573_CR8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1517\/13543784.15.8.917","volume":"5","author":"D Barb","year":"2006","unstructured":"Barb D, Pazaitou-Panayiotou K, Mantzoros CS (2006) Adiponectin: a link between obesity and cancer. Expert Opin Investig Drugs 5:917\u2013931","journal-title":"Expert Opin Investig Drugs"},{"key":"9573_CR9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.bjc.6602896","volume":"94","author":"E Petridou","year":"2006","unstructured":"Petridou E, Mantzoros CS, Dessypris N, Dikalioti SK, Trichopoulos D (2006) Adiponectin in relation to childhood myeloblastic leukaemia. Br J Cancer 94:156\u2013160","journal-title":"Br J Cancer"},{"key":"9573_CR10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","volume":"94","author":"I Kelesidis","year":"2006","unstructured":"Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94:1221\u20131225","journal-title":"Br J Cancer"},{"key":"9573_CR11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0960-9822(02)70684-2","volume":"6","author":"BD Bennett","year":"1996","unstructured":"Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W (1996) A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 6:1170\u20131180","journal-title":"Curr Biol"},{"key":"9573_CR12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF02982810","volume":"76","author":"H Wex","year":"2002","unstructured":"Wex H, Ponelis E, Wex T, Dressendorfer R, Mittler U, Vorwerk P (2002) Plasma leptin and leptin receptor expression in childhood acute lymphoblastic leukemia. Int J Hematol 76:446\u2013452","journal-title":"Int J Hematol"},{"key":"9573_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/10428190009148392","volume":"36","author":"M Hino","year":"2000","unstructured":"Hino M, Nakao T, Yamane T, Ohta K, Takubo T, Tatsumi N (2000) Leptin receptor and leukemia. Leuk Lymphoma 36:457\u2013461","journal-title":"Leuk Lymphoma"},{"key":"9573_CR14","first-page":"241","volume":"8","author":"GE Pamuk","year":"2006","unstructured":"Pamuk GE, Demir M, Harmandar F, Yesil Y, Turgut B, Vural O (2006) Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics. Exp Oncol 8:241\u2013244","journal-title":"Exp Oncol"},{"key":"9573_CR15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1998.00843.x","volume":"102","author":"T Nakao","year":"1998","unstructured":"Nakao T, Hino M, Yamane T, Nishizawa Y, Morii H, Tatsumi N (1998) Expression of the leptin receptor in human leukaemic blast cells. Br J Haematol 102:740\u2013745","journal-title":"Br J Haematol"},{"key":"9573_CR16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941\u2013946","journal-title":"Nat Med"},{"key":"9573_CR17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/cr.2007.14","volume":"17","author":"Y Wang","year":"2007","unstructured":"Wang Y, Lam KS, Xu A (2007) Adiponectin as a negative regulator in obesity-related mammary carcinogenesis. Cell Res 17:280\u2013282","journal-title":"Cell Res"},{"key":"9573_CR18","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1073\/pnas.0308671100","volume":"101","author":"E Brakenhielm","year":"2004","unstructured":"Brakenhielm E, Veitonmaki N, Cao R et al (2004) Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci 101:2476\u20132481","journal-title":"Proc Natl Acad Sci"},{"key":"9573_CR19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439\u2013451","journal-title":"Endocr Rev"},{"key":"9573_CR20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/en.2004-1096","volume":"146","author":"H Waki","year":"2005","unstructured":"Waki H, Yamauchi T, Kamon J et al (2005) Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146:790\u2013796","journal-title":"Endocrinology"},{"key":"9573_CR21","doi-asserted-by":"crossref","first-page":"40352","DOI":"10.1074\/jbc.M300365200","volume":"278","author":"H Waki","year":"2003","unstructured":"Waki H, Yamauchi T, Kamon J et al (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352\u201340363","journal-title":"J Biol Chem"},{"key":"9573_CR22","doi-asserted-by":"crossref","first-page":"30817","DOI":"10.1074\/jbc.M402367200","volume":"279","author":"A Tsuchida","year":"2004","unstructured":"Tsuchida A, Yamauchi T, Ito Y et al (2004) Insulin\/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279:30817\u201330822","journal-title":"J Biol Chem"},{"key":"9573_CR23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","volume":"423","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762\u2013769","journal-title":"Nature"},{"key":"9573_CR24","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/jc.2006-1858","volume":"92","author":"A Korner","year":"2007","unstructured":"Korner A, Pazaitou-Panayiotou K, Kelesidis T et al (2007) Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92:1041\u20131048","journal-title":"J Clin Endocrinol Metab"},{"key":"9573_CR25","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ejca.2008.04.015","volume":"44","author":"M Dalamaga","year":"2008","unstructured":"Dalamaga M, Karmaniolas K, Nikolaidou A et al (2008) Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system. Eur J Cancer 44:1744\u20131753","journal-title":"Eur J Cancer"},{"key":"9573_CR26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000120995","volume":"73","author":"M Dalamaga","year":"2007","unstructured":"Dalamaga M, Nikolaidou A, Karmaniolas K et al (2007) Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study. Oncology 73:26\u201332","journal-title":"Oncology"},{"key":"9573_CR27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10552-008-9233-7","volume":"20","author":"M Dalamaga","year":"2009","unstructured":"Dalamaga M, Karmaniolas K, Panagiotou A et al (2009) Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study. Cancer Causes Control 20:193\u2013199","journal-title":"Cancer Causes Control"},{"key":"9573_CR28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1532\/IJH97.NA0411","volume":"83","author":"F Avcu","year":"2006","unstructured":"Avcu F, Ural AU, Yilmaz MI, Bingol N, Nevruz O, Caglar K (2006) Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases. Int J Hematol 83:254\u2013258","journal-title":"Int J Hematol"},{"key":"9573_CR29","first-page":"537","volume":"25","author":"GE Pamuk","year":"2006","unstructured":"Pamuk GE, Turgut B, Demir M, Vural O (2006) Increased adiponectin level in non-Hodgkin lymphoma and its relationship with interleukin-10. Correlation with clinical features and outcome. J Exp Clin Cancer Res 25:537\u2013541","journal-title":"J Exp Clin Cancer Res"},{"key":"9573_CR30","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"BD Cheson","year":"1996","unstructured":"Cheson BD, Bennett JM, Grever M et al (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87:4990\u20134997","journal-title":"Blood"},{"key":"9573_CR31","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","volume":"10","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J et al (1999) The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 10:1419\u20131432","journal-title":"Ann Oncol"},{"key":"9573_CR32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","volume":"48","author":"JL Binet","year":"1981","unstructured":"Binet JL, Auquier A, Dighiero G et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198\u2013206","journal-title":"Cancer"},{"key":"9573_CR33","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1046\/j.1365-2141.1997.3263141.x","volume":"98","author":"DG Oscier","year":"1997","unstructured":"Oscier DG, Matutes E, Copplestone A et al (1997) Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Hematol 98:934\u2013939","journal-title":"Br J Hematol"},{"key":"9573_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008995217664","volume":"12","author":"A Wolk","year":"2001","unstructured":"Wolk A, Gridley G, Svensson M et al (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13\u201321","journal-title":"Cancer Causes Control"},{"key":"9573_CR35","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V96.5.1723","volume":"96","author":"T Yokota","year":"2000","unstructured":"Yokota T, Oritani K, Takahashi I et al (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723\u20131732","journal-title":"Blood"},{"key":"9573_CR36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1677\/ERC-07-0065","volume":"14","author":"L Cong","year":"2007","unstructured":"Cong L, Gasser J, Zhao J, Yang B, Li F, Zhao AZ (2007) Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Endocr Relat Cancer 14:713\u2013720","journal-title":"Endocr Relat Cancer"},{"key":"9573_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-2007-956518","volume":"39","author":"JD Arditi","year":"2007","unstructured":"Arditi JD, Venihaki M, Karalis KP, Chrousos GP (2007) Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Hormone and metabolic research Hormon- und Stoffwechselforschung 39:9\u201313","journal-title":"Hormone and metabolic research Hormon- und Stoffwechselforschung"},{"key":"9573_CR38","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.1158\/0008-5472.CAN-06-1969","volume":"66","author":"Y Wang","year":"2006","unstructured":"Wang Y, Lam JB, Lam KS et al (2006) Adiponectin modulates the glycogen synthase kinase-3beta\/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 66:11462\u201311470","journal-title":"Cancer Res"},{"key":"9573_CR39","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.4049\/jimmunol.178.6.3511","volume":"178","author":"L DiMascio","year":"2007","unstructured":"DiMascio L, Voermans C, Uqoezwa M et al (2007) Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 178:3511\u201335120","journal-title":"J Immunol"},{"key":"9573_CR40","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1158\/1078-0432.CCR-05-1033","volume":"11","author":"PO Iversen","year":"2005","unstructured":"Iversen PO, Wiig H (2005) Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis. Clin Cancer Res 11:6793\u20136799","journal-title":"Clin Cancer Res"},{"key":"9573_CR41","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.4049\/jimmunol.171.10.5091","volume":"171","author":"T Yokota","year":"2003","unstructured":"Yokota T, Meka CS, Kouro T et al (2003) Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 171:5091\u20135099","journal-title":"J Immunol"},{"key":"9573_CR42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10620-007-9922-1","volume":"53","author":"PC Konturek","year":"2008","unstructured":"Konturek PC, Burnat G, Rau T, Hahn EG, Konturek S (2008) Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci 53:597\u2013605","journal-title":"Dig Dis Sci"},{"key":"9573_CR43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12185-008-0165-5","volume":"88","author":"S Molica","year":"2008","unstructured":"Molica S, Vitelli G, Cutrona G et al (2008) Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia. Int J Hematol 88:374\u2013380","journal-title":"Int J Hematol"},{"key":"9573_CR44","first-page":"584","volume":"87","author":"\u00d8 Bruserud","year":"2002","unstructured":"Bruserud \u00d8, Huang TS, Glenjen N, Gjertsen BT, Foss B (2002) Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts. Haematologica 87:584\u2013595","journal-title":"Haematologica"},{"key":"9573_CR45","first-page":"57","volume":"10","author":"NA Hamed","year":"2003","unstructured":"Hamed NA, Sharaki OA, Zeidan MM (2003) Leptin in acute leukaemias: relationship to interleukin-6 and vascular endothelial growth factor. Egypt J Immunol 10:57\u201366","journal-title":"Egypt J Immunol"},{"key":"9573_CR46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","volume":"334","author":"R Considine","year":"1996","unstructured":"Considine R, Sinha M, Heiman M (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292\u2013295","journal-title":"N Engl J Med"},{"key":"9573_CR47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.physbeh.2006.05.038","volume":"88","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Scarpace P (2006) The role of leptin in leptin resistance and obesity. Physiol Behav 88:249\u2013256","journal-title":"Physiol Behav"},{"key":"9573_CR48","first-page":"3419","volume":"81","author":"G Boden","year":"1996","unstructured":"Boden G, Chen X, Mozzoli M, Ryan I (1996) Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81:3419\u20133423","journal-title":"J Clin Endocrinol Metab"},{"key":"9573_CR49","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200317490","volume":"11","author":"J Chan","year":"2003","unstructured":"Chan J, Heist K, DePaoli A, Veldhuis J (2003) The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 11:1409\u20131421","journal-title":"J Clin Invest"},{"key":"9573_CR50","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1073\/pnas.93.25.14564","volume":"93","author":"T Gainsford","year":"1996","unstructured":"Gainsford T, Willson TA, Metcalf D et al (1996) Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 93:14564\u201314568","journal-title":"Proc Natl Acad Sci USA"},{"key":"9573_CR51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1189\/jlb.68.4.437","volume":"68","author":"G Fantuzzi","year":"2000","unstructured":"Fantuzzi G, Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68:437\u2013446","journal-title":"J Leukoc Biol"},{"key":"9573_CR52","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood.V93.5.1668","volume":"93","author":"M Konopleva","year":"1999","unstructured":"Konopleva M, Mikhail A, Estrov Z et al (1999) Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood 93:1668\u20131676","journal-title":"Blood"},{"key":"9573_CR53","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bone.2004.06.008","volume":"35","author":"HS Berner","year":"2004","unstructured":"Berner HS, Lyngstadaas SP, Spahr A et al (2004) Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842\u2013849","journal-title":"Bone"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-010-9573-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-010-9573-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-010-9573-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T02:57:01Z","timestamp":1685588221000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-010-9573-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,8]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9573"],"URL":"https:\/\/doi.org\/10.1007\/s10552-010-9573-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,8]]}}}